Calcitonin Salmon Injection, Solution
NDC Package 70710-1875-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Calcitonin Salmon injection is hypersensitivity to calcitonin salmon or any of the excipients. This formulation utilizes a injection, solution delivery system. Marketed by Zydus Pharmaceuticals Usa Inc., this product is identified by NDC 70710-1875 and is authorized under FDA application ANDA215864.

Identification & Billing

NDC Package Code
70710-1875-1
Package Description
1 VIAL, MULTI-DOSE in 1 CARTON / 2 mL in 1 VIAL, MULTI-DOSE
Product Code
70710-1875
11-Digit Billing Format
70710187501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Calcitonin Salmon
Non-Proprietary Name
Calcitonin Salmon
Substance Name
Calcitonin Salmon
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
CALCITONIN SALMON 200 [USP'U]/mL
Pharmacologic Class
Usage Information
Hypersensitivity to calcitonin salmon or any of the excipients. Reactions have included anaphylaxis with death, bronchospasm, and swelling of the tongue or throat [see Warnings and Precautions (5.1)].

Regulatory & Marketing

Labeler Name
Zydus Pharmaceuticals Usa Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA215864
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-10-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70710-1875-1 identifies a specific commercial package of 1 vial, multi-dose in 1 carton / 2 ml in 1 vial, multi-dose of Calcitonin Salmon, a human prescription drug labeled by Zydus Pharmaceuticals Usa Inc.. This injection, solution is formulated for intramuscular; subcutaneous use and contains calcitonin salmon as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Pharmaceuticals Usa Inc. on April 10, 2026. The current certification is valid through December 31, 2027.

How is this Zydus Pharmaceuticals Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70710187501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70710-1875-1
11-Digit CMS (5-4-2)
70710-1875-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.